Sonic may well have the contract (I thougth all pathology providers could do it), but you suspect in a few years that the number of FIT tests will be approximating zero if the RHY test is superior and easier. Its not a threat, as FIT is the one threatened.
You do realise that the $12b or total market opportunity refers to the value of tests. Only some of that will flow through to RHY. That amount is the biggest drivers of the various DCFs floating around
- Forums
- ASX - By Stock
- RHY
- Ann: CE Mark Granted for ColoSTAT
Ann: CE Mark Granted for ColoSTAT, page-32
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHY (ASX) to my watchlist
|
|||||
Last
6.2¢ |
Change
0.002(3.33%) |
Mkt cap ! $15.41M |
Open | High | Low | Value | Volume |
6.0¢ | 6.2¢ | 5.6¢ | $13.88K | 236.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 38000 | 6.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.2¢ | 144741 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 38000 | 0.060 |
1 | 8908 | 0.057 |
1 | 17855 | 0.056 |
1 | 54545 | 0.055 |
1 | 68500 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.062 | 144741 | 1 |
0.063 | 34 | 1 |
0.065 | 9750 | 1 |
0.066 | 80000 | 1 |
0.070 | 75394 | 2 |
Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online